Biomaterial Database

[Phosphate binders for therapy of hyperphosphatemia causing secondary hyperparathyroidism and renal osteodystrophy in patients with chronic renal failure]. 1991

S Kanagawa, and Y Yosikawa, and Y Dohi

Second Department of Internal Medicine, Saitama Medical School.

UI	MeSH Term	Description	Entries
D006962	Hyperparathyroidism, Secondary	Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.	Secondary Hyperparathyroidism,Hyperparathyroidisms, Secondary,Secondary Hyperparathyroidisms
D007676	Kidney Failure, Chronic	The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.	ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008276	Magnesium Hydroxide	An inorganic compound that occurs in nature as the mineral brucite. It acts as an antacid with cathartic effects.	Brucite,Magnesium Hydrate,Magnesium Hydroxide (Mg(OH)4),Hydrate, Magnesium,Hydroxide, Magnesium
D010710	Phosphates	Inorganic salts of phosphoric acid.	Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D012080	Chronic Kidney Disease-Mineral and Bone Disorder	Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.	Renal Osteodystrophy,Renal Rickets,Rickets, Renal,CKD-MBD,Osteodystrophy, Renal,Chronic Kidney Disease Mineral and Bone Disorder,Osteodystrophies, Renal,Renal Osteodystrophies
D002951	Citrates	Derivatives of CITRIC ACID.
D004338	Drug Combinations	Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.	Drug Combination,Combination, Drug,Combinations, Drug
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085	Acetates	Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure.	Acetate,Acetic Acid Esters,Acetic Acids,Acids, Acetic,Esters, Acetic Acid
D000481	Allantoin	A urea hydantoin that is found in URINE and PLANTS and is used in dermatological preparations.	Herpecin-L,Sebical,Woun'dres,Herpecin L,HerpecinL

Related Publications

S Kanagawa, and Y Yosikawa, and Y Dohi

Phosphate binders in hyperphosphatemia of chronic renal failure.

September 1991, DICP : the annals of pharmacotherapy,

S Kanagawa, and Y Yosikawa, and Y Dohi

Cardiovascular mortality in chronic renal failure: hyperphosphatemia, coronary calcification, and the role of phosphate binders.

January 2002, Cleveland Clinic journal of medicine,

S Kanagawa, and Y Yosikawa, and Y Dohi

Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.

July 1970, The Quarterly journal of medicine,

S Kanagawa, and Y Yosikawa, and Y Dohi

[Renal osteodystrophy and secondary hyperparathyroidism].

March 1995, Zhonghua nei ke za zhi,

S Kanagawa, and Y Yosikawa, and Y Dohi

Renal osteodystrophy and secondary hyperparathyroidism.

January 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

S Kanagawa, and Y Yosikawa, and Y Dohi

Secondary hyperparathyroidism and renal osteodystrophy.

April 1995, Canadian journal of surgery. Journal canadien de chirurgie,

S Kanagawa, and Y Yosikawa, and Y Dohi

[Renal osteodystrophy and secondary hyperparathyroidism].

June 2002, Clinical calcium,

S Kanagawa, and Y Yosikawa, and Y Dohi

Hyperphosphatemia and phosphate binders.

November 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,

S Kanagawa, and Y Yosikawa, and Y Dohi

[Physiopathology and therapy of renal osteodystrophy and secondary hyperparathyroidism].

July 1999, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,